PI3Kβ inhibition enhances ALK‐inhibitor sensitivity in ALK‐rearranged lung cancer.

MLA

Talwelkar, Sarang S., et al. “PI3Kβ Inhibition Enhances ALK‐inhibitor Sensitivity in ALK‐rearranged Lung Cancer.” Molecular Oncology, vol. 17, no. 5, May 2023, pp. 747–64. EBSCOhost, https://doi.org/10.1002/1878-0261.13342.

APA

Talwelkar, S. S., Mäyränpää, M. I., Schüler, J., Linnavirta, N., Hemmes, A., Adinolfi, S., Kankainen, M., Sommergruber, W., Levonen, A., Räsänen, J., Knuuttila, A., Verschuren, E. W., & Wennerberg, K. (2023). PI3Kβ inhibition enhances ALK‐inhibitor sensitivity in ALK‐rearranged lung cancer. Molecular Oncology, 17(5), 747–764. https://doi.org/10.1002/1878-0261.13342

Chicago

Talwelkar, Sarang S., Mikko I. Mäyränpää, Julia Schüler, Nora Linnavirta, Annabrita Hemmes, Simone Adinolfi, Matti Kankainen, et al. 2023. “PI3Kβ Inhibition Enhances ALK‐inhibitor Sensitivity in ALK‐rearranged Lung Cancer.” Molecular Oncology 17 (5): 747–64. doi:10.1002/1878-0261.13342.